Health and Healthcare
Eli Lilly (LLY): The Drug Companies Never Learn
Published:
At least once a year, and probably more often, a big drug company makes a settlement or faces suits over not disclosing the bad effects of one or more of its products.
Lilly’s anti-psychotic drug Zyprexa can cause severe weight gain which can lead to diabetes. Investigators clearly think that someone at Lilly knew this. As The Wall Street Journal points out "the prospect of an indictment is daunting for a drug maker in light of the government’s huge role in health care, since a criminal finding could compromise a company’s access to government business."
Lilly may pay as much as $1 billion to settle with the feds and state governments. Then all of its Zyprexa problems will go away like bad dreams.
The settlement hardly gets to the heart of the matter which is that drug companies appear to be routinely prepared to be overly aggressive in marketing their products. Lawsuits are part of the cost of doing business. Lilly made over $1 billion last quarter. The charge for settling this matter will probably be spread over more than one year.
The drug company culture is deeply flawed and undermined by an acceptance of deception. Prosecutors and the FDA know that. But, they seem not to be willing to do much about it.
Douglas A. McIntyre
The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.
Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!
Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!
Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.